Compare NSP & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NSP | COLL |
|---|---|---|
| Founded | 1986 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 1997 | 2015 |
| Metric | NSP | COLL |
|---|---|---|
| Price | $38.55 | $48.67 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $47.67 | $47.50 |
| AVG Volume (30 Days) | ★ 910.8K | 498.8K |
| Earning Date | 11-03-2025 | 11-06-2025 |
| Dividend Yield | ★ 6.24% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.45 | ★ 1.63 |
| Revenue | ★ $6,757,000,000.00 | $757,067,000.00 |
| Revenue This Year | $4.71 | $26.35 |
| Revenue Next Year | $6.40 | $3.67 |
| P/E Ratio | $85.99 | ★ $29.92 |
| Revenue Growth | 3.19 | ★ 26.34 |
| 52 Week Low | $31.00 | $23.23 |
| 52 Week High | $95.98 | $49.16 |
| Indicator | NSP | COLL |
|---|---|---|
| Relative Strength Index (RSI) | 57.67 | 70.71 |
| Support Level | $34.14 | $46.15 |
| Resistance Level | $36.32 | $49.16 |
| Average True Range (ATR) | 1.32 | 1.32 |
| MACD | 0.84 | -0.16 |
| Stochastic Oscillator | 90.83 | 92.11 |
Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.